Vaccinex Inc
NASDAQ:VCNX
Vaccinex Inc
NASDAQ:VCNX
Price:
0.65
USD
-26.97%
Market Cap:
$3.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vaccinex Inc
NASDAQ:VCNX
|
US |
|
Shopify Inc
NASDAQ:SHOP
|
CA |
|
A
|
Agent Information Software Inc
OTC:AIFS
|
US |
|
Japan Exchange Group Inc
TSE:8697
|
JP |
|
T
|
Titan Invo Technology Ltd
HKEX:872
|
HK |
|
Kedawung Setia Industrial Tbk PT
IDX:KDSI
|
ID |
|
N
|
Nike Inc
SWB:NKE
|
US |
|
S
|
Silver Hammer Mining Corp
CNSX:HAMR
|
CA |
|
Gold Terra Resource Corp
XTSX:YGT
|
CA |
|
West African Resources Ltd
ASX:WAF
|
AU |
|
R
|
Raghuvir Synthetics Ltd
BSE:514316
|
IN |
|
I
|
InnoTek Ltd
SGX:M14
|
SG |
|
T
|
Twinhead International Corp
TWSE:2364
|
TW |
|
O
|
Onelife Capital Advisors Ltd
NSE:ONELIFECAP
|
IN |
Balance Sheet
Balance Sheet Decomposition
Vaccinex Inc
Vaccinex Inc
Balance Sheet Decomposition is not available for
Vaccinex Inc
Vaccinex Inc
Balance Sheet
Vaccinex Inc
Vaccinex Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
2
|
4
|
6
|
3
|
11
|
9
|
6
|
2
|
1
|
|
| Cash Equivalents |
2
|
4
|
6
|
3
|
11
|
9
|
6
|
2
|
1
|
|
| Short-Term Investments |
0
|
0
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
2
|
5
|
21
|
4
|
11
|
9
|
7
|
3
|
3
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
6
|
6
|
6
|
7
|
7
|
7
|
7
|
7
|
7
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
6
+96%
|
22
+295%
|
5
-79%
|
12
+154%
|
10
-16%
|
8
-19%
|
4
-54%
|
3
-29%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
2
|
2
|
2
|
3
|
3
|
1
|
2
|
2
|
4
|
|
| Accrued Liabilities |
2
|
2
|
4
|
4
|
2
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
|
| Total Current Liabilities |
4
|
4
|
7
|
7
|
13
|
2
|
3
|
6
|
5
|
|
| Long-Term Debt |
1
|
3
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
12
|
24
|
24
|
24
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
6
N/A
|
19
+213%
|
31
+59%
|
31
+1%
|
38
+24%
|
2
-94%
|
3
+15%
|
6
+113%
|
5
-14%
|
|
| Equity | ||||||||||
| Common Stock |
111
|
119
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Retained Earnings |
169
|
187
|
217
|
249
|
277
|
300
|
320
|
340
|
359
|
|
| Additional Paid In Capital |
54
|
54
|
208
|
222
|
251
|
307
|
325
|
338
|
354
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
14
-313%
|
9
+37%
|
26
-204%
|
27
-1%
|
7
N/A
|
5
-30%
|
2
N/A
|
2
-8%
|
|
| Total Liabilities & Equity |
3
N/A
|
6
+96%
|
22
+295%
|
5
-79%
|
12
+154%
|
10
-16%
|
8
-19%
|
4
-54%
|
3
-29%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
|
Switch to:
Switch to:
See Also
Discover More
